Literature DB >> 2198281

Kinetic mechanism of dihydropyrimidine dehydrogenase from pig liver.

B Podschun1, P F Cook, K D Schnackerz.   

Abstract

Data on initial velocity and isotope exchange at equilibrium suggest a nonclassical ping-pong mechanism for the dihydropyrimidine dehydrogenase from pig liver. Initial velocity patterns in the absence of inhibitors appeared parallel at low reactant concentration, with substrate inhibition by NADPH that is competitive with uracil and with substrate inhibition by uracil that is uncompetitive with NADPH. The Km values for both uracil (1 microM) and NADPH (7 microM) are low. As a result, it was difficult to determine whether the initial velocity pattern in the absence of added inhibitors was parallel. Thus, the pattern was redetermined in the presence of the dead-end inhibitor 2,6-dihydroxypyridine, which binds to both sites. This treatment effectively eliminates the inhibition by both substrates and increases their Km values, giving a strictly parallel pattern. Product and dead-end inhibition patterns are consistent with a mechanism in which NADPH reduces the enzyme at site 1 and electrons are transferred to site 2 to reduce uracil to dihydrouracil. The predicted mechanism is corroborated by exchange between [14C] NADP and NADPH as well as [14C]thymine and dihydrothymine in the absence of the other substrate-product pair.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2198281

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil.

Authors:  D Dobritzsch; G Schneider; K D Schnackerz; Y Lindqvist
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

2.  Identification of fungal dihydrouracil-oxidase genes by expression in Saccharomyces cerevisiae.

Authors:  Jonna Bouwknegt; Aurin M Vos; Raúl A Ortiz Merino; Daphne C van Cuylenburg; Marijke A H Luttik; Jack T Pronk
Journal:  Antonie Van Leeuwenhoek       Date:  2022-10-14       Impact factor: 2.158

3.  Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.

Authors:  Lauren Edwards; Rohit Gupta; Fabian Volker Filipp
Journal:  Mol Cancer Res       Date:  2015-11-25       Impact factor: 5.852

4.  A ferredoxin-dependent dihydropyrimidine dehydrogenase in Clostridium chromiireducens.

Authors:  Feifei Wang; Yifeng Wei; Qiang Lu; Ee Lui Ang; Huimin Zhao; Yan Zhang
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

5.  Force Field Parameters for Fe2+4S2-4 Clusters of Dihydropyrimidine Dehydrogenase, the 5-Fluorouracil Cancer Drug Deactivation Protein: A Step towards In Silico Pharmacogenomics Studies.

Authors:  Maureen Bilinga Tendwa; Lorna Chebon-Bore; Kevin Lobb; Thommas Mutemi Musyoka; Özlem Tastan Bishop
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.